AbuBakar S, Sam IC, et al. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis. 2009;15(1):79–82.
Ang LW, Koh BK, et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore. 2009;38(2):106–12.
Anonymos. Forum on Hand Foot and Mouth Disease (HFMD) in Asia-Pacific Region: Epidemiological, Laboratory, Clinical, and Public Health aspects. Singapore, Regional Emerging Disease Intervention Center & The Ministry of Health Singapore: 17; 2009.
Anonymous. Forum on Hand Foot and Mouth Disease (HFMD) in Asia-Pacific Region: Epidemiological, Laboratory, Clinical, and Public Health aspects. Singapore, Regional Emerging Disease Intervention Center & The Ministry of Health Singapore: 17; 2009.
Arita M, Shimizu H, et al. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol. 2005;86(5):1391–401.
Baker AB. Poliomyelitis. A study of pulmonary edema. Neurology. 1957;7(11):743–51.
Bessaud M, Pillet S, et al. Molecular characterization of human enteroviruses in the Central African Republic: uncovering wide diversity and identification of a New human enterovirus A71 genogroup. J Clin Microbiol. 2012;50(5):1650–8.
Bible JM, Iturriza-Gomara M, et al. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J Clin Microbiol. 2008;46(10):3192–200.
Blomberg J, Lycke E, et al. New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet. 1974;2(7872):112.
Brown B, Kilpatrick D, et al. Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol. 2000;16:107–12.
Brown BA, Oberste MS, et al. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999;73(12):9969–75.
Cardosa M, Perera D, et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis. 2003;9(4):461–8.
Cardosa MJ, Krishnan S, et al. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet. 1999;354(9183):987–91.
Castro CM, Cruz AC, et al. Molecular and seroepidemiologic studies of Enterovirus 71 infection in the State of Para, Brazil. Rev Inst Med Trop Sao Paulo. 2005;47(2):65–71.
Chakraborty R, Iturriza-Gomara M, et al. An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS. 2004;18(14):1968–70.
Chan K, Goh K, et al. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9:78–85.
Chan L, Parashar U, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis. 2000;31:678–83.
Chan YF, Abu Bakar S. Virucidal activity of Virkon S on human enterovirus. Med J Malaysia. 2005;60(2):246–8.
Chang L-Y, Chang IS, et al. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics. 2008;122(6):1271–6.
Chang L-Y, Hsia S-H, et al. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J. 2004;23(4):327–31.
Chang L-Y, Huang L-M, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007;356(12):1226–34.
Chang L-Y, Huang Y-C, et al. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet. 1998;352(9125):367–8.
Chang L-Y, King C-C, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002;109(6):e88.
Chang L-Y, Tsao K-C, et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA. 2004;291(2):222–7.
Chang L, Lin T, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354(9191):1682–6.
Chang SC, Li WC, et al. Efficacy of alcohols and alcohol-based hand disinfectants against human enterovirus 71. J Hosp Infect. 2013;83(4):288–93.
Chatproedprai S, Theanboonlers A, et al. Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008–2009. Jpn J Infect Dis. 2010;63(4):229–33.
Chen C-Y, Chang Y-C, et al. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol. 2001;22(1):200–5.
Chen C-Y, Chang Y-C, et al. MR imaging findings of epidemic enterovirus 71 encephalitis in infants and young children. Chin J Radiol. 2000;25(2):45–52.
Chen CH, Hsu BM, et al. Molecular detection and prevalence of enterovirus within environmental water in Taiwan. J Appl Microbiol. 2008;104(3):817–23.
Chen CS, Yao YC, et al. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol. 2007;81(17):8996–9003.
Chen J, Tong J, et al. Increased frequency of Th17 cells in the peripheral blood of children infected with enterovirus 71. J Med Virol. 2012;84(5):763–7.
Chen K, Chang H, et al. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics. 2007;120(2):244–52.
Chen T-C, Chen G-W, et al. Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16. J Clin Microbiol. 2006;44(6):2212–9.
Chen T-C, Weng K-F, et al. Development of antiviral agents for enteroviruses. J Antimicrob Chemother. 2008;62(6):1169–73.
Chen YC, Yu CK, et al. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol. 2004;85:69–77.
Chi C-Y, Khanh TH, et al. Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial*. Crit Care Med. 2013;41(7):1754–60. doi:10.1097/CCM.0b013e31828a2a85.
Chong CY, Chan KP, et al. Hand, foot and mouth disease in Singapore: a comparison of fatal and non-fatal cases. Acta Paediatr. 2003;92(10):1163–9.
Chua KB, Chua BH, et al. Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia. Malays J Pathol. 2007;29(2):69–78.
Chumakov M, Voroshilova M, et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60(3–4):329–40.
Chung P-W, Huang Y-C, et al. Duration of enterovirus shedding in stool. J Microbiol Immunol Infect. 2001;34(3):167–70.
Da Silva EE, Winkler MT, et al. Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. MD Computing. 1996;13(4):231–3.
Deibel R, Flanagan TD. Central nervous system infections. Etiologic and epidemiologic observations in New York State, 1976-1977. N Y State J Med. 1979;79(5):689–95.
Deshpande JM, Nadkarni SS, et al. Enterovirus 71 isolated from a case of acute flaccid paralysis in India represents a new genotype. Curr Sci. 2003;84(10):1350–3.
Fu Y-C, Chi C-S, et al. Pulmonary edema of enterovirus 71 encephalomyelitis is associated with left ventricular failure: implications for treatment. Pediatr Pulmonol. 2003;35(4):263–8.
Fu YC, Chi CS, et al. Cardiac complications of enterovirus rhombencephalitis. Arch Dis Child. 2004;89(4):368–73.
Fu YC, Chi CS, et al. Comparison of heart failure in children with enterovirus 71 rhombencephalitis and cats with norepinephrine cardiotoxicity. Pediatr Cardiol. 2006;27(5):577–84.
Fujimoto T, Yoshida S, et al. Detection and quantification of enterovirus 71 genome from cerebrospinal fluid of an encephalitis patient by PCR applications. Jpn J Infect Dis. 2008;61(6):497–9.
Gau SS, Chang LY, et al. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics. 2008;122(2):e452–8.
German AC, Myint KS, et al. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg. 2006;100(12):1135–45.
Gilbert GLMFF, Dickson KEBAS, et al. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J. 1988;7(7):484–7.
Griffiths MJ, Ooi MH, et al. In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1β, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. J Infect Dis. 2012;206(6):881–92.
Guan D, van der Sanden S, Zeng H, Li W, Zheng H, Ma C, Su J, Liu Z, Guo X, Zhang X, Liu L, Koopmans M, Ke C. Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010. PLoS One. 2012;7(9):e44386. doi:10.1371/journal.pone.0044386. Epub 2012 Sep 12.
Hagiwara A, Tagaya I, et al. Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology. 1978;9(1):60–3.
Han J, Ma X-J, et al. Long persistence of EV71 specific nucleotides in respiratory and feces samples of the patients with Hand-Foot-Mouth Disease after recovery. BMC Infect Dis. 2010;10(1):178.
Ho M, Chen ER, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med. 1999;341(13):929–35.
Hoff JT, Nishimura M, et al. Experimental neurogenic pulmonary edema. Part 1: the role of systemic hypertension. J Neurosurg. 1981;54(5):627–31.
Honkanen H, Oikarinen S, et al. Human enterovirus 71 strains in the background population and in hospital patients in Finland. J Clin Virol. 2012;56(4):348–53.
Hosoya M, Kawasaki Y, et al. Genetic diversity of enterovirus 71 associated with hand, foot and mouth disease epidemics in Japan from 1983 to 2003. Pediatr Infect Dis J. 2006;25(8):691–4.
Hsia SH, Wu CT, et al. Predictors of unfavorable outcomes in enterovirus 71-related cardiopulmonary failure in children. Pediatr Infect Dis J. 2005;24(4):331–4.
Hsu BM, Chen CH, et al. Prevalence of enteroviruses in hot spring recreation areas of Taiwan. FEMS Immunol Med Microbiol. 2008;52(2):253–9.
Hsueh C, Jung SM, et al. Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod Pathol. 2000;13(11):1200–5.
Huang C-C, Liu C-C, et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936–42.
Huang SW, Hsu YW, et al. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol. 2009;47(11):3653–62.
Huang Y-F, Chiu P-C, et al. Cardiac troponin I: a reliable marker and early myocardial involvement with meningoencephalitis after fatal enterovirus-71 infection. J Infect. 2003;46(4):238–43.
Huang YP, Lin TL, et al. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res. 2008;137(2):206–12.
Ishimaru Y, Nakano S, et al. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child. 1980;55(8):583–8.
Iwai M, Masaki A, et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis. 2009;62(4):254–9.
Jan SL, Lin SJ, et al. Extracorporeal life support for treatment of children with enterovirus 71 infection-related cardiopulmonary failure. Intensive Care Med. 2009;36(3):520–7.
Jee YM, Cheon D-S, et al. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol. 2003;148(9):1735–46.
Jeong EJ, Lee JH, et al. Molecular characterization of enteroviruses detected in Gyeong-Ju and Po-Hang provinces of Korea in 2003. Arch Virol. 2010;155(10):1707–12.
Jesus NHD. Epidemics to eradication: the modern history of poliomyelitis. Virol J. 2007;4:70.
Kadurugamuwa JL, Shaheen E. Inactivation of human enterovirus 71 and coxsackie virus A16 and hand, foot, and mouth disease. Am J Infect Control. 2011;39(9):788–9.
Kennett ML, Birch CJ, et al. Enterovirus type 71 infection in Melbourne. Bull World Health Organ. 1975;51(6):609–15.
Khanh TH, Sabanathan S, et al. Enterovirus 71–associated hand, foot, and mouth disease, southern Vietnam, 2011. Emerg Infect Dis. 2012;18(12).
Komatsu H, Shimizu Y, et al. Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol. 1999;20(1):17–23.
Kung SH, Wang SF, et al. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clin Microbiol Infect. 2007;13(8):782–7.
Lee MS, Tseng FC, et al. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis. 2012;6(8):e1737.
Li L, He Y, et al. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People’s Republic of China. J Clin Microbiol. 2005;43(8):3835–9.
Li Y-P, Liang Z-L, et al. Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial. Vaccine. 2012;30(22):3295–303.
Lian Z, Huang B, et al. Diffusion-weighted imaging in the diagnosis of enterovirus 71 encephalitis. Acta Radiol. 2012;53(2):208–13.
Lin K-H, Hwang K-P, et al. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol. 2006;78(2):254–62.
Lin M-T, Wang J-K, et al. Heart rate variability monitoring in the detection of central nervous system complications in children with enterovirus infection. J Crit Care. 2006;21(3):280–6.
Lin T-Y, Hsia S-H, et al. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis. 2003;36(3):269–74.
Lin TY, Chang LY, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis. 2002;34 Suppl 2.
Lin TY, Chang LY, et al. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 2002;91(6):632–5 (Oslo, Norway: 1992).
Lin Y, Wen K, et al. Cross-reactivity of anti-Ev71 IgM and neutralizing antibody in series sera of patients infected with Enterovirus 71 and Coxsackievirus A 16. J Immunoassay Immunochem. 2011;32(3):233–43.
Liu MY, Liu W, et al. Characterization of an outbreak of hand, foot, and mouth disease in Nanchang, China in 2010. PLoS One. 2011;6(9):e25287.
Lu C-Y, Lee C-Y, et al. Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J Med Virol. 2002;67(2):217–23.
Lu H-K, Lin T-Y, et al. Prognostic implications of myoclonic jerk in children with enterovirus infection. J Microbiol Immunol Infect. 2004;37(2):82–7.
Lum LC, Wong KT, et al. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet. 1998;352(9137):1391.
Lum LC, Wong KT, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998;133(6):795–8.
Lv T, Li J, et al. Association of interleukin-17F gene polymorphism with enterovirus 71 encephalitis in patients with hand, foot, and mouth disease. Inflammation. 2013;36(4):977–81.
Ma E, Fung C, et al. Estimation of the basic reproduction number of enterovirus 71 and coxsackievirus A16 in hand, foot, and mouth disease outbreaks. Pediatr Infect Dis J. 2011;30(8):675–9. doi:10.1097/INF.0b013e3182116e95.
Ma E, Wong S, et al. Effects of public health interventions in reducing transmission of hand, foot, and mouth disease. Pediatr Infect Dis J. 2011;30(5):432–5. doi:10.1097/INF.0b013e3182127782.
McMinn P. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26(1):91–107.
McMinn P, Lindsay K, et al. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 2001;75:7732–8.
McMinn P, Stratov I, et al. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32(2):236–42.
McMinn PC. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol. 2012;2(2):199–205.
Merovitz L, Demers A-M, et al. Enterovirus 71 infections at a canadian center. Pediatr Infect Dis J. 2000;19(8):755–7.
Mizuta K, Abiko C, et al. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol. 2005;43(12):6171–5.
Mizuta K, Aoki Y, et al. Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine. 2009;27(24):3153–8.
Nagy G, Takatsy S, et al. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol. 1982;71(3):217–27.
Nasri D, Bouslama L, et al. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev Mol Diagn. 2007;7(4):419–34.
Ni H, Yi B, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008–2011. J Clin Virol. 2012;54(4):342–8.
Nishimura Y, Shimojima M, et al. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794–7.
Ong KC, Badmanathan M, et al. Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J Neuropathol Exp Neurol. 2008;67(6):532–42.
Ooi M, Wong S, et al. Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. 2009;9(1):3.
Ooi MH, Solomon T, et al. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. J Clin Microbiol. 2007;45(6):1858–66.
Ooi MH, Wong SC, et al. Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. Clin Infect Dis. 2003;36(5):550–9.
Ooi MH, Wong SC, et al. Clinical features, diagnosis and management of human enterovirus 71 infection. Lancet Neurol. 2010;9(11):1097–105.
Ooi MH, Wong SC, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007;44(5):646–56.
Ortner B, Huang CW, et al. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol. 2009;81(2):317–24.
Pallansch MA, Ross RP. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Fields Virol. 2001;1:723–75.
Perera D, Podin Y, et al. Incorrect identification of recent Asian strains of coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT-PCR. BMC Infect Dis. 2004;4:11.
Perez-Velez CM, Anderson MS, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007;45(8):950–7.
Phan P, Dau H, et al. Continuous veno-venous hemofiltration for treatment of enterovirus 71-induced fulminant cardiopulmonary failure: a case report. J Med Case Reports. 2012;6(1):159.
Plevka P, Perera R, et al. Crystal structure of human enterovirus 71. Science. 2012;336(6086):1274.
Podin Y, Gias E, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health. 2006;6(1):180.
Prager P, Nolan M, et al. Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors. Pediatr Crit Care Med. 2003;4(3):377–81.
Puenpa J, Theamboonlers A, et al. Molecular characterization and complete genome analysis of human enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Thailand during 2008–2011. Arch Virol. 2011;156(11):2007–13.
Rotbart HA. Antiviral therapy for enteroviruses and rhinoviruses. Antivir Chem Chemother. 2000;11(4):261–71.
Rotbart HA, O’Connell JF, et al. Treatment of human enterovirus infections. Antiviral Res. 1998;38(1):1–14.
Rotbart HA, Webster AD. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis. 2001;32(2):228–35.
Ryu W-S, Kang B, et al. Clinical and etiological characteristics of enterovirus 71-related diseases during a recent 2-year period in Korea. J Clin Microbiol. 2010;48(7):2490–4.
Samuda GM, Chang WK, et al. Monoplegia caused by Enterovirus 71: an outbreak in hong Kong. Pediatr Infect Dis J. 1987;6(2):206–8.
Sanders SA, Herrero LJ, et al. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol. 2006;151(5):1003–13.
Schmidt N, Lennette E, et al. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304–9.
Seiff A. Cambodia unravels cause of mystery illness. Lancet. 2012;380(9838):205.
Badran SA, Midgley S, et al. Clinical and virological features of enterovirus 71 infections in Denmark, 2005 to 2008. Scand J Infect Dis. 2011;43(8):642–8.
Shen W-C, Chiu H-H, et al. MR imaging findings of enteroviral encephalomyelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol. 1999;20(10):1889–95.
Shen WC, Tsai C-H, et al. MRI of Enterovirus 71 myelitis with monoplegia. Neuroradiology. 2000;42(2):124–7.
Shieh W-J, Jung S-M, et al. Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerg Infect Dis. 2001;7(1):146–8.
Shih S-R, Wang Y-W, et al. Serotype-specific detection of enterovirus 71 in clinical specimens by DNA microchip array. J Virol Methods. 2003;111(1):55–60.
Shih S, Ho M, et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res. 2000;68(2):127–36.
Shimizu H. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatr Int. 2004;46:231–5.
Shindarov LM, Chumakov MP, et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol. 1979;23(3):284–95.
Siafakas N, Attilakos A, et al. Molecular detection and identification of enteroviruses in children admitted to a university hospital in Greece. Mol Cell Probes. 2011;25(5–6):249–54.
Singh S, Poh C, et al. Complete sequence analyses of enterovirus 71 strains from fatal and non-fatal cases of the hand, foot and mouth disease outbreak in Singapore (2000). Microbiol Immunol. 2002;46(11):801–8.
Solomon T, Lewthwaite P, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778–90.
Tan CY, Gonfrier G, et al. Screening and detection of human enterovirus 71 infection by a real-time RT-PCR assay in Marseille, France, 2009–2011. Clin Microbiol Infect. 2012;18(4):E77–80.
Tan EL, Chow VT, et al. Development of multiplex real-time hybridization probe reverse transcriptase polymerase chain reaction for specific detection and differentiation of Enterovirus 71 and Coxsackievirus A16. Diagn Microbiol Infect Dis. 2008;61(3):294–301.
Tao Z, Wang H, et al. Identification of a C2 subgenogroup strain of enterovirus 71 in a retrospective study in Shandong Province, China, from 1990 to 2010. J Clin Microbiol. 2012;50(5):1823–4.
Tee KK, Lam TT, et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J Virol. 2010;84(7):3339–50.
Tsou YA, Cheng YK, et al. Upper aerodigestive tract sequelae in severe enterovirus 71 infection: predictors and outcome. Int J Pediatr Otorhinolaryngol. 2008;72(1):41–7.
Tu PV, Thao NT, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007;13(11):1733–41.
van der Sanden S, Koopmans M, et al. Epidemiology of enterovirus 71 in The Netherlands, 1963 to 2008. J Clin Microbiol. 2009;47(9):2826–33.
Van der Sanden S, Van der Avoort H, et al. Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses. J Gen Virol. 2010;91:1949–58.
Wang J-R, Tuan Y-C, et al. Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000. J Clin Microbiol. 2002;40(1):10–5.
Wang JN, Yao CT, et al. Critical management in patients with severe enterovirus 71 infection. Pediatr Int. 2006;48(3):250–6.
Wang S-M, Lei H-Y, et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: Roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188(4):564–70.
Wang S-M, Liu C-C, et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999;29(1):184–90.
Wang S-Y, Lin T-L, et al. Early and rapid detection of enterovirus 71 infection by an IgM-capture ELISA. J Virol Methods. 2004;119(1):37–43.
Wang S, Lei H, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37(1):47–52.
Wang SM, Lei HY, et al. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr Pulmonol. 2005;39(3):219–23.
Wang SM, Lei HY, et al. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis. 2008;198(7):1002–6.
Wang X, Peng W, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol. 2012;19(4):424–9.
Wang YF, Chou CT, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78(15):7916–24.
Welch J, Maclaran K, et al. Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors. Transfusion. 2003;43(8):1060–6.
WHO. A guide to clinical management and public health response for Hand, Foot and Mouth Disease (HFMD, 2011). http://www.wpro.who.int/publications/docs/Guidanceforthe clinicalmanagementofHFMD.pdf. Accessed 6 Aug 2013.
Witso E, Palacios G, et al. Asymptomatic circulation of HEV71 in Norway. Virus Res. 2007;123(1):19–29.
Wong KT, Lum LC, et al. Enterovirus 71 infection and neurologic complications. N Engl J Med. 2000;342(5):356–8.
Wong KT, Munisamy B, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. 2008;67(2):162–9.
Wong KT, Ng KY, et al. Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA. Neuropathol Appl Neurobiol. 2012;38(5):443–53.
Wu JM, Wang JN, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics. 2002;109(2).
Wu Y, Yeo A, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: The role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14(12):e1076–81.
Xiao XL, He YQ, et al. Simultaneous detection of human enterovirus 71 and coxsackievirus A16 in clinical specimens by multiplex real-time PCR with an internal amplification control. Arch Virol. 2009;154(1):121–5.
Xu F, Yan Q, et al. Performance of detecting IgM antibodies against enterovirus 71 for early diagnosis. PLoS One. 2010;5(6):e11388.
Xu J, Qian Y, Wang S, Serrano JM, Li W, Huang Z, Lu S. EV71: an emerging infectious disease vaccine target in the Far East? Vaccine. 2010;28(20):3516–21.
Yamayoshi S, Yamashita Y, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798–801.
Yang F, Ren L, et al. Enterovirus 71 outbreak in the People’s Republic of China in 2008. J Clin Microbiol. 2009;47(7):2351–2.
Yang J, Zhao N, et al. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease. Scand J Infect Dis. 2012;44(6):465–9.
Yang KD, Yang MY, et al. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J Infect Dis. 2001;183(6):850–6.
Yu H, Chen W, et al. Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008. Virus Genes. 2010;41(41):1–4.
Zeng H, Wen F, Gan Y, Huang W. MRI and associated clinical characteristics of EV71-induced brainstem encephalitis in children with hand-foot-mouth disease. Neuroradiology. 2012;54(6):623–30. doi:10.1007/s00234-011-0979-3. Epub 2011 Dec 28.
Zhang D, Lu J, et al. Enterovirus 71 vaccine: close but still far. Int J Infect Dis. 2010;14(9):e739–43.
Zhang Y, Tan X-J, et al. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 2009;44(4):262–7.
Zhang Y, Zhu Z, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China. Virol J. 2010;7(1):94.
Zheng X-Q, Chen X-Q, et al. Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71. Clin Exp Med. 2013;1–7.
Zhu F-C, Meng F-Y, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381(9882):2024–32.